ABOUT CONOLIDINE

These benefits, together with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the principle of concentrating on ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Problems.Depending on readily available science